Sfoglia per RIVISTA
CANCERS
Collezione AOU Città della Salute di Torino
Items : 101
Unlocking the Therapeutic Potential of Algae-Derived Compounds in Hematological Malignancies. in Cancers / Cancers (Basel). 2025 Jan 20;17(2):318. doi: 10.3390/cancers17020318.
2025
AOU Città della Salute di Torino
Vujovi? T; Paradžik T; Babi? Br?i? S; Piva R;
The Rare Entity of Basaloid Thymic Carcinoma: A Multicentric Retrospective Analysis from the Italian Collaborative Group for ThYmic MalignanciEs (TYME). in Cancers / Cancers (Basel). 2025 Jan 13;17(2):239. doi: 10.3390/cancers17020239.
2025
AOU Città della Salute di Torino
Catania C; Manglaviti S; Zucali P; Perrino M; Ruffini E; Di Tommaso L; Mazzella A; Spaggiari L; Delmonte A; Lo Russo G; Garassino M; Solli P; Pasello G; Rosso L; Lococo F; Rindi G; Ricciardi S; Picozzi F; Lyberis P; Tinterri B; Pala L; Conforti F; De Pas T;
WT1 Expression Is Associated with Poor Overall Survival after Azacytidine and DLI in a Cohort of Adult AML and MDS Patients. in Cancers / Cancers (Basel). 2024 Sep 4;16(17):3070. doi: 10.3390/cancers16173070.
2024
AOU Città della Salute di Torino
Aydin S; Schmitz J; Dellacasa CM; Dogliotti I; Giaccone L; Busca A;
Haemodynamic Forces: Emerging Markers of Ventricular Remodelling in Multiple Myeloma Cardiovascular Baseline Risk Assessment. in Cancers / Cancers (Basel). 2024 Sep 4;16(17):3081. doi: 10.3390/cancers16173081.
2024
AOU Città della Salute di Torino
Colomba A; Astarita A; Mingrone G; Airale L; Catarinella C; Vallelonga F; Leone D; Cesareo M; Paladino A; Bringhen S; Gay F; Pedrizzetti G; Veglio F; Milan A;
IDH2 Inhibitors Gain a Wildcard Status in the Cancer Therapeutics Competition. in Cancers / Cancers (Basel). 2024 Sep 26;16(19):3280. doi: 10.3390/cancers16193280.
2024
AOU Città della Salute di Torino
Piva R; Gharari N; Labrador M; Mader S;
Molecular and Clinical Features of Adrenocortical Tumors in Beckwith-Wiedemann Spectrum. in Cancers / Cancers (Basel). 2024 Nov 26;16(23):3967. doi: 10.3390/cancers16233967.
2024
AOU Città della Salute di Torino
Carli D; Rondot F; Luca M; Campello A; Vallero SG; Tirtei E; Gazzin A; Cardaropoli S; Montanari F; Graziano C; Quarello P; Saadat A; Sparago A; Ferrero GB; Fagioli F; Mussa A;
Correction: Colomba et al. Haemodynamic Forces: Emerging Markers of Ventricular Remodelling in Multiple Myeloma Cardiovascular Baseline Risk Assessment. Cancers 2024, 16, 3081. in Cancers / Cancers (Basel). 2024 Nov 21;16(23):3891. doi: 10.3390/cancers16233891.
2024
AOU Città della Salute di Torino
Colomba A; Astarita A; Mingrone G; Airale L; Catarinella C; Vallelonga F; Leone D; Cesareo M; Paladino A; Bringhen S; Gay F; Pedrizzetti G; Veglio F; Milan A;
Advances in Hodgkin Lymphoma Treatment: From Molecular Biology to Clinical Practice. in Cancers / Cancers (Basel). 2024 May 10;16(10):1830. doi: 10.3390/cancers16101830.
2024
AOU Città della Salute di Torino
Benevolo Savelli C; Bisio M; Legato L; Fasano F; Santambrogio E; Nicolosi M; Morra D; Boccomini C; Freilone R; Botto B; Novo M;
Real-World Outcome of Treatment with Single-Agent Ibrutinib in Italian Patients with Chronic Lymphocytic Leukemia: Final Results of the EVIdeNCE Study. in Cancers / Cancers (Basel). 2024 Mar 20;16(6):1228. doi: 10.3390/cancers16061228.
2024
AOU Città della Salute di Torino
Mauro FR; Scalzulli PR; Scarfò L; Minoia C; Murru R; Sportoletti P; Frigeri F; Albano F; Di Renzo N; Sanna A; Laurenti L; Massaia M; Cassin R; Coscia M; Patti C; Pennese E; Tafuri A; Chiarenza A; Galieni P; Perbellini O; Selleri C; Califano C; Ferrara F; Cuneo A; Murineddu M; Palumbo G; Scortechini I; Tedeschi A; Trentin L; et alii...
Liver Transplantation for Hepatocellular Carcinoma in the Era of Immune Checkpoint Inhibitors. in Cancers / Cancers (Basel). 2024 Jun 28;16(13):2374. doi: 10.3390/cancers16132374.
2024
AOU Città della Salute di Torino
De Stefano N; Patrono D; Colli F; Rizza G; Paraluppi G; Romagnoli R;
What Does Atypical Chronic Lymphocytic Leukemia Really Mean? A Retrospective Morphological and Immunophenotypic Study. in Cancers / Cancers (Basel). 2024 Jan 22;16(2):469. doi: 10.3390/cancers16020469.
2024
AOU Città della Salute di Torino
D'Arena G; Vitale C; Pietrantuono G; Villani O; Mansueto G; D'Auria F; Statuto T; D'Agostino S; Sabetta R; Tarasco A; Innocenti I; Autore F; Fresa A; Valvano L; Tomasso A; Cafaro L; Lamorte D; Laurenti L;
Maintain Efficacy and Spare Toxicity: Traditional and New Radiation-Based Conditioning Regimens in Hematopoietic Stem Cell Transplantation. in Cancers / Cancers (Basel). 2024 Feb 21;16(5):865. doi: 10.3390/cancers16050865.
2024
AOU Città della Salute di Torino
Ricardi U; Giaccone L; Bruno B; Cerrano M; Maffini E; Cavallin C; Felicetti F; Bartoncini S; Martin A; Levis M; Dogliotti I;
Bispecific Antibodies for Lymphoid Malignancy Treatment. in Cancers / Cancers (Basel). 2024 Dec 31;17(1):94. doi: 10.3390/cancers17010094.
2024
AOU Città della Salute di Torino
Bisio M; Legato L; Fasano F; Benevolo Savelli C; Boccomini C; Nicolosi M; Santambrogio E; Freilone R; Novo M; Botto B;
The Impact of Lateral Ventricular Opening in the Resection of Newly Diagnosed High-Grade Gliomas: A Single Center Experience. in Cancers / Cancers (Basel). 2024 Apr 19;16(8):1574. doi: 10.3390/cancers16081574.
2024
AOU Città della Salute di Torino
Cofano F; Bianconi A; De Marco R; Consoli E; Zeppa P; Bruno F; Pellerino A; Panico F; Salvati LF; Rizzo F; Morello A; Rudà R; Morana G; Melcarne A; Garbossa D;
Second Neoplasms in Italian Patients with Hairy Cell Leukemia after Treatment with Cladribine: A Multicenter Investigation and Literature Review. in Cancers / Cancers (Basel). 2024 Apr 11;16(8):1475. doi: 10.3390/cancers16081475.
2024
AOU Città della Salute di Torino
Criscuolo M; Tosti ME; Broccoli A; Varettoni M; Maraglino AME; Anastasia A; Cantonetti M; Trentin L; Kovalchuk S; Orsucci L; Deodato M; Spolzino A; Volpetti S; Annibali O; Storti S; Stelitano C; Marchesi F; Morè S; Fianchi L; Falini B; Pulsoni A; Tiacci E; Zinzani PL; Pagano L;
Outcomes of a Diagnostic Pathway for Prostate Cancer Based on Biparametric MRI and MRI-Targeted Biopsy Only in a Large Teaching Hospital. in Cancers / Cancers (Basel). 2023 Sep 29;15(19):4800. doi: 10.3390/cancers15194800.
2023
AOU Città della Salute di Torino
Paulino Pereira LJ; Reesink DJ; de Bruin P; Gandaglia G; van der Hoeven EJRJ; Marra G; Prinsen A; Rajwa P; Soeterik T; Kasivisvanathan V; Wever L; Zattoni F; van Melick HHE; van den Bergh RCN;
Blinatumomab and Inotuzumab Ozogamicin Sequential Use for the Treatment of Relapsed/Refractory Acute Lymphoblastic Leukemia: A Real-Life Campus All Study. in Cancers / Cancers (Basel). 2023 Sep 19;15(18):4623. doi: 10.3390/cancers15184623.
2023
AOU Città della Salute di Torino
AOU Novara
Foà R; Curti A; Passamonti F; Sartor C; Buzzatti E; Barozzi E; De Roberto P; Canzi M; Santoro L; Tagliaferri E; Zappasodi P; Cerrano M; Del Principe MI; Defina M; Todisco E; Gurrieri C; Dargenio M; Bonifacio M; Scappini B; Imovilli A; Lunghi M; Lazzarotto D; Forghieri F; Salutari P; Annunziata M; Giglio F; Chiaretti S; Vitale A; Papayannidis C; et alii...
A Prognostic Model to Predict Ruxolitinib Discontinuation and Death in Patients with Myelofibrosis. in Cancers / Cancers (Basel). 2023 Oct 17;15(20):5027. doi: 10.3390/cancers15205027.
2023
AOU Città della Salute di Torino
Palandri F; Palumbo GA; Bonifacio M; Elli EM; Tiribelli M; Auteri G; Trawinska MM; Polverelli N; Benevolo G; Tieghi A; Cavalca F; Caocci G; Beggiato E; Binotto G; Cavazzini F; Miglino M; Bosi C; Crugnola M; Bocchia M; Martino B; Pugliese N; Venturi M; Isidori A; Cattaneo D; Krampera M; Pane F; Cilloni D; Semenzato G; Lemoli RM; et alii...
Antibody Response to the SARS-CoV-2 Vaccine and COVID-19 Vulnerability during the Omicron Pandemic in Patients with CLL: Two-Year Follow-Up of a Multicenter Study. in Cancers / Cancers (Basel). 2023 May 30;15(11):2993. doi: 10.3390/cancers15112993.
2023
AOU Città della Salute di Torino
Mauro FR; Giannarelli D; Galluzzo CM; Visentin A; Frustaci AM; Sportoletti P; Vitale C; Reda G; Gentile M; Levato L; Murru R; Armiento D; Molinari MC; Proietti G; Pepe S; De Falco F; Mattiello V; Barabino L; Amici R; Coscia M; Tedeschi A; Girmenia C; Trentin L; Baroncelli S;
Graft-Versus-Host Disease Prophylaxis with Antithymocyte Globulin in Patients Receiving Stem Cell Transplantation from Unrelated Donors: An Observational Retrospective Single-Center Study. in Cancers / Cancers (Basel). 2023 May 15;15(10):2761. doi: 10.3390/cancers15102761.
2023
AOU Città della Salute di Torino
Lo Schirico M; Passera R; Gill J; Dellacasa C; Dogliotti I; Giaccone L; Zompi S; Busca A;
New Strategies for the Treatment of Older Myeloma Patients. in Cancers / Cancers (Basel). 2023 May 10;15(10):2693. doi: 10.3390/cancers15102693.
2023
AOU Città della Salute di Torino
Larocca A; Cani L; Bertuglia G; Bruno B; Bringhen S;
Evaluating the Protective Effect of Intravesical Bacillus Calmette-Guerin against SARS-CoV-2 in Non-Muscle Invasive Bladder Cancer Patients: A Multicenter Observational Trial. in Cancers / Cancers (Basel). 2023 Mar 6;15(5):1618. doi: 10.3390/cancers15051618.
2023
AOU Città della Salute di Torino
Hurle R; Soria F; Contieri R; Avolio PP; Mancon S; Lazzeri M; Bernasconi V; Mazzoli S; Pizzuto G; De Bellis M; Rosazza M; Livoti S; Lupia T; Corcione S; Lillaz B; De Rosa FG; Buffi NM; Kamat AM; Gontero P; Casale P;
Modern Risk Stratification of Acute Myeloid Leukemia in 2023: Integrating Established and Emerging Prognostic Factors. in Cancers / Cancers (Basel). 2023 Jul 6;15(13):3512. doi: 10.3390/cancers15133512.
2023
AOU Città della Salute di Torino
Boscaro E; Urbino I; Catania FM; Arrigo G; Secreto C; Olivi M; D'Ardia S; Frairia C; Giai V; Freilone R; Ferrero D; Audisio E; Cerrano M;
Phenotypic and Dermoscopic Patterns of Familial Melanocytic Lesions: A Pilot Study in a Third-Level Center. in Cancers / Cancers (Basel). 2023 Jul 25;15(15):3772. doi: 10.3390/cancers15153772.
2023
AOU Città della Salute di Torino
Roccuzzo G; Giordano S; Granato T; Cavallo F; Mastorino L; Avallone G; Pasini B; Quaglino P; Ribero S;
Predictors of Response to Hydroxyurea and Switch to Ruxolitinib in HU-Resistant Polycythaemia VERA Patients: A Real-World PV-NET Study. in Cancers / Cancers (Basel). 2023 Jul 21;15(14):3706. doi: 10.3390/cancers15143706.
2023
AOU Città della Salute di Torino
Palandri F; Rossi E; Auteri G; Breccia M; Paglia S; Benevolo G; Elli EM; Cavazzini F; Binotto G; Tieghi A; Tiribelli M; Heidel FH; Bonifacio M; Pugliese N; Caocci G; Crugnola M; Mendicino F; D'Addio A; Tomassetti S; Martino B; Polverelli N; Ceglie S; Mazzoni C; Mullai R; Ripamonti A; Garibaldi B; Pane F; Cuneo A; Krampera M; et alii...
Multicenter Observational Retrospective Study on Febrile Events in Patients with Acute Myeloid Leukemia Treated with Cpx-351 in "Real-Life": The SEIFEM Experience. in Cancers / Cancers (Basel). 2023 Jul 1;15(13):3457. doi: 10.3390/cancers15133457.
2023
AOU Città della Salute di Torino
Fianchi L; Guolo F; Marchesi F; Cattaneo C; Gottardi M; Restuccia F; Candoni A; Ortu La Barbera E; Fazzi R; Pasciolla C; Finizio O; Fracchiolla N; Delia M; Lessi F; Dargenio M; Bonuomo V; Del Principe MI; Zappasodi P; Picardi M; Basilico C; Piedimonte M; Minetto P; Giordano A; Chiusolo P; Prezioso L; Buquicchio C; Melillo LMA; Zama D; Farina F; et alii...
The Emerging Role of PET/CT with PSMA-Targeting Radiopharmaceuticals in Clear Cell Renal Cancer: An Updated Systematic Review. in Cancers / Cancers (Basel). 2023 Jan 5;15(2):355. doi: 10.3390/cancers15020355.
2023
AOU Città della Salute di Torino
Rizzo A; Racca M; Dall'Armellina S; Rescigno P; Banna GL; Albano D; Dondi F; Bertagna F; Annunziata S; Treglia G;
Ki67 as a Predictor of Response to PARP Inhibitors in Platinum Sensitive BRCA Wild Type Ovarian Cancer: The MITO 37 Retrospective Study. in Cancers / Cancers (Basel). 2023 Feb 6;15(4):1032. doi: 10.3390/cancers15041032.
2023
AO Ordine Mauriziano
AOU Città della Salute di Torino
Borsotti L; Paolini B; Puppo A; Marinaccio M; Cormio G; Carella C; Mandato VD; Parisi A; Sikokis A; Biglia N; Mammoliti S; Zanchi L; Artioli G; Maldi E; Andreetta C; Raspagliesi F; Picardo E; Pignata S; Ghisoni E; Tuninetti V; Scotto G; Turinetto M; Sangiolo D; Di Maio M; Valabrega G;
Combining the HCT-CI, G8, and AML-Score for Fitness Evaluation of Elderly Patients with Acute Myeloid Leukemia: A Single Center Analysis. in Cancers / Cancers (Basel). 2023 Feb 4;15(4):1002. doi: 10.3390/cancers15041002.
2023
AOU Città della Salute di Torino
Aydin S; Passera R; Cerrano M; Giai V; D'Ardia S; Iovino G; Dellacasa CM; Audisio E; Busca A;
Variation in Post-Transplant Cancer Incidence among Italian Kidney Transplant Recipients over a 25-Year Period. in Cancers / Cancers (Basel). 2023 Feb 20;15(4):1347. doi: 10.3390/cancers15041347.
2023
AOU Città della Salute di Torino
AOU Novara
Argiolas D; Ambrosini A; Simone S; Mangino M; Cantaluppi V; Tisone G; Veroux M; Citterio F; Campise M; Iaria M; Todeschini P; Bossini N; Busnach G; Biancone L; Furian L; Cimaglia C; Serraino D; Piselli P; Pisani F; Caputo F; Taborelli M;
Carfilzomib-Based Regimen and Cardiotoxicity in Multiple Myeloma: Incidence of Cardiovascular Events and Organ Damage in Carfilzomib-Dexamethasone versus Carfilzomib-Lenalidomide-Dexamethasone. A Real-Life Prospective Study. in Cancers / Cancers (Basel). 2023 Feb 2;15(3):955. doi: 10.3390/cancers15030955.
2023
AOU Città della Salute di Torino
Astarita A; Mingrone G; Airale L; Cesareo M; Colomba A; Catarinella C; Leone D; Gay F; Bringhen S; Veglio F; Milan A; Vallelonga F;
Implications of an Underlying Beckwith-Wiedemann Syndrome for Wilms Tumor Treatment Strategies. in Cancers / Cancers (Basel). 2023 Feb 17;15(4):1292. doi: 10.3390/cancers15041292.
2023
AOU Città della Salute di Torino
Quarello P; Carli D; Biasoni D; Gerocarni Nappo S; Morosi C; Cotti R; Garelli E; Zucchetti G; Spadea M; Tirtei E; Spreafico F; Fagioli F;
Patients with Very High Risk of Cardiovascular Adverse Events during Carfilzomib Therapy: Prevention and Management of Events in a Single Center Experience. in Cancers / Cancers (Basel). 2023 Feb 10;15(4):1149. doi: 10.3390/cancers15041149.
2023
AOU Città della Salute di Torino
Mingrone G; Astarita A; Colomba A; Catarinella C; Cesareo M; Airale L; Paladino A; Leone D; Vallelonga F; Bringhen S; Gay F; Veglio F; Milan A;
Clinical Outcomes of HER2-Negative Metastatic Breast Cancer Patients in Italy in the Last Decade: Results of the GIM 13-AMBRA Study. in Cancers / Cancers (Basel). 2023 Dec 25;16(1):117. doi: 10.3390/cancers16010117.
2023
ASL Città di Torino
AOU Città della Salute di Torino
AOU Novara
Bria E; Cognetti F; Crinò L; De Laurentiis M; Del Mastro L; De Placido S; Beano A; Zambelli A; Mustacchi G; Turletti A; Verusio C; Tonini G; Tinari N; Spazzapan S; Tagliaferri P; Romagnoli E; Sarobba G; Mattioli R; Michelotti A; Montemurro F; Putzu C; Riccardi F; Ricciardi G; Marchetti P; Livi L; Giotta F; Giovanardi F; Latini L; Gennari A; et alii...
Chimeric Antigen Receptor-T Cell Therapy for Lymphoma: New Settings and Future Directions. in Cancers / Cancers (Basel). 2023 Dec 21;16(1):46. doi: 10.3390/cancers16010046.
2023
AOU Città della Salute di Torino
Benevolo Savelli C; Clerico M; Botto B; Secreto C; Cavallo F; Dellacasa C; Busca A; Bruno B; Freilone R; Cerrano M; Novo M;
MITO39: Efficacy and Tolerability of Pegylated Liposomal Doxorubicin (PLD)-Trabectedin in the Treatment of Relapsed Ovarian Cancer after Maintenance Therapy with PARP Inhibitors-A Multicenter Italian Trial in Ovarian Cancer Observational Case-Control Study. in Cancers / Cancers (Basel). 2023 Dec 20;16(1):41. doi: 10.3390/cancers16010041.
2023
AO Ordine Mauriziano
AOU Città della Salute di Torino
Tuninetti V; Picardo E; Vertechy L; Bergamini A; Palaia I; Artioli G; Parisi A; Scandurra G; Scollo P; Baldoni A; Malaguti P; Cassani C; Zamagni C; Pisano C; Ricotti A; Marchetti C; Turinetto M; Scotto G; Scambia G; Pignata S; Valabrega G;
Euchromatic Histone Lysine Methyltransferase 2 Inhibition Enhances Carfilzomib Sensitivity and Overcomes Drug Resistance in Multiple Myeloma Cell Lines. in Cancers / Cancers (Basel). 2023 Apr 7;15(8):2199. doi: 10.3390/cancers15082199.
2023
AOU Città della Salute di Torino
Mereu E; Abbo D; Paradzik T; Cumerlato M; Bandini C; Labrador M; Maccagno M; Ronchetti D; Manicardi V; Neri A; Piva R;
Employment among Childhood Cancer Survivors: A Systematic Review and Meta-Analysis. in Cancers / Cancers (Basel). 2022 Sep 22;14(19):4586. doi: 10.3390/cancers14194586.
2022
AOU Città della Salute di Torino
Godono A; Felicetti F; Conti A; Clari M; Dionisi-Vici M; Gatti F; Ciocan C; Pinto T; Arvat E; Brignardello E; Fagioli F; Pira E;
Urinary Zinc Loss Identifies Prostate Cancer Patients. in Cancers / Cancers (Basel). 2022 Oct 28;14(21):5316. doi: 10.3390/cancers14215316.
2022
AOU Città della Salute di Torino
Maddalone MG; Oderda M; Mengozzi G; Gesmundo I; Novelli F; Giovarelli M; Gontero P; Occhipinti S;
Advances and Hurdles in CAR T Cell Immune Therapy for Solid Tumors. in Cancers / Cancers (Basel). 2022 Oct 18;14(20):5108. doi: 10.3390/cancers14205108.
2022
AOU Città della Salute di Torino
Boccalatte F; Mina R; Aroldi A; Leone S; Suryadevara CM; Placantonakis DG; Bruno B;
Conversion Strategy in Left-Sided RAS/BRAF Wild-Type Metastatic Colorectal Cancer Patients with Unresectable Liver-Limited Disease: A Multicenter Cohort Study. in Cancers / Cancers (Basel). 2022 Nov 9;14(22):5513. doi: 10.3390/cancers14225513.
2022
ASL Torino 4
AOU Città della Salute di Torino
Garrone O; Facciorusso A; Memeo R; de Angelis N; Germini A; Gjoni E; Roberto M; De Tursi M; Morelli C; Berardi R; Giampieri R; Depetris I; Zurlo IV; Gelsomino F; Nigro O; Filippi R; Salvatore L; Bonomi A; Cotsoglou C; Granieri S; Ramai D; Ghidini M; Parisi A;
Sinonasal Side Effects of Chemotherapy and/or Radiation Therapy for Head and Neck Cancer: A Literature Review. in Cancers / Cancers (Basel). 2022 May 7;14(9):2324. doi: 10.3390/cancers14092324.
2022
AOU Città della Salute di Torino
Riva G; Cravero E; Pizzo C; Briguglio M; Iorio GC; Cavallin C; Ostellino O; Airoldi M; Ricardi U; Pecorari G;
FLT3-ITD in Children with Early T-cell Precursor (ETP) Acute Lymphoblastic Leukemia: Incidence and Potential Target for Monitoring Minimal Residual Disease (MRD). in Cancers / Cancers (Basel). 2022 May 17;14(10):2475. doi: 10.3390/cancers14102475.
2022
AOU Città della Salute di Torino
Lo Nigro L; Andriano N; Buldini B; Silvestri D; Villa T; Locatelli F; Parasole R; Barisone E; Testi AM; Biondi A; Valsecchi MG; Rizzari C; Conter V; Basso G; Cazzaniga G;
Molecular Imaging and Theragnostics of Thyroid Cancers. in Cancers / Cancers (Basel). 2022 Mar 1;14(5):1272. doi: 10.3390/cancers14051272.
2022
AOU Città della Salute di Torino
Giovanella L; Deandreis D; Vrachimis A; Campenni A; Petranovic Ovcaricek P;
Management of Nutritional Needs in Pediatric Oncology: A Consensus Statement. in Cancers / Cancers (Basel). 2022 Jul 11;14(14):3378. doi: 10.3390/cancers14143378.
2022
AOU Città della Salute di Torino
Fabozzi F; Trovato CM; Diamanti A; Mastronuzzi A; Zecca M; Tripodi SI; Masetti R; Leardini D; Muratore E; Barat V; Lezo A; De Lorenzo F; Caccialanza R; Pedrazzoli P;
Blinatumomab in Children and Adolescents with Relapsed/Refractory B Cell Precursor Acute Lymphoblastic Leukemia: A Real-Life Multicenter Retrospective Study in Seven AIEOP (Associazione Italiana di Ematologia e Oncologia Pediatrica) Centers. in Cancers / Cancers (Basel). 2022 Jan 15;14(2):426. doi: 10.3390/cancers14020426.
2022
AOU Città della Salute di Torino
Beneduce G; De Matteo A; Stellato P; Testi AM; Bertorello N; Colombini A; Putti MC; Rizzari C; Cesaro S; Cellini M; Barisone E; Petruzziello F; Menna G; Parasole R;
Long-Term Hepatocellular Carcinoma Development and Predictive Ability of Non-Invasive Scoring Systems in Patients with HCV-Related Cirrhosis Treated with Direct-Acting Antivirals. in Cancers / Cancers (Basel). 2022 Feb 6;14(3):828. doi: 10.3390/cancers14030828.
2022
AOU Città della Salute di Torino
Caviglia GP; Troshina G; Santaniello U; Rosati G; Bombaci F; Birolo G; Nicolosi A; Saracco GM; Ciancio A;
The Association between Patient Characteristics and the Efficacy and Safety of Selinexor in Diffuse Large B-Cell Lymphoma in the SADAL Study. in Cancers / Cancers (Basel). 2022 Feb 4;14(3):791. doi: 10.3390/cancers14030791.
2022
AOU Città della Salute di Torino
Zijlstra JM; Follows G; Casasnovas RO; Vermaat JSP; Kalakonda N; Choquet S; Hill B; Thieblemont C; Cavallo F; Cruz F; Kuruvilla J; Hamad N; Jaeger U; Caimi P; Gurion R; Warzocha K; Bakhshi S; Sancho JM; Schuster M; Egyed M; Offner F; Vassilakopoulos TP; Samal P; Ku M; Xu J; Corona K; Chamoun K; Shah J; Canales M; et alii...
Prostate Cancer in Renal Transplant Recipients: Results from a Large Contemporary Cohort. in Cancers / Cancers (Basel). 2022 Dec 28;15(1):189. doi: 10.3390/cancers15010189.
2022
AOU Città della Salute di Torino
Marra G; Soria F; Peretti F; Oderda M; Dariane C; Timsit MO; Branchereau J; Hedli O; Mesnard B; Tilki D; Olsburgh J; Kulkarni M; Kasivisvanathan V; Lebacle C; Rodriguez-Faba O; Breda A; Soeterik T; Gandaglia G; Todeschini P; Biancone L; Gontero P; On Behalf Of The Collaborators;
Post-Translational Modifications in Tumor-Associated Antigens as a Platform for Novel Immuno-Oncology Therapies. in Cancers / Cancers (Basel). 2022 Dec 26;15(1):138. doi: 10.3390/cancers15010138.
2022
AOU Città della Salute di Torino
Srivastava AK; Guadagnin G; Cappello P; Novelli F;
Serum Extracellular Vesicle-Derived microRNAs as Potential Biomarkers for Pleural Mesothelioma in a European Prospective Study. in Cancers / Cancers (Basel). 2022 Dec 25;15(1):125. doi: 10.3390/cancers15010125.
2022
AOU Alessandria
AOU Città della Salute di Torino
Schulze MB; Trobajo-Sanmartín C; Heath AK; Riboli E; Huerta JM; Tumino R; Kaaks R; Johnson T; Agnoli C; Panico S; Smith-Byrne K; Rodriguez-Barranco M; Sacerdote C; Rena O; Filiberti RA; Mirabelli D; Grosso F; Dianzani I; Sculco M; Magnani C; Ferrante D; Mencoboni M; Catalano C; Allione A; Russo A; Pardini B; Birolo G; Casalone E; Saieva C; et alii...
A Systematic Review of Amino Acid PET Imaging in Adult-Type High-Grade Glioma Surgery: A Neurosurgeon's Perspective. in Cancers / Cancers (Basel). 2022 Dec 23;15(1):90. doi: 10.3390/cancers15010090.
2022
AOU Città della Salute di Torino
De Marco R; Pesaresi A; Bianconi A; Zotta M; Deandreis D; Morana G; Zeppa P; Melcarne A; Garbossa D; Cofano F;
PSMA Radioligand Uptake as a Biomarker of Neoangiogenesis in Solid Tumours: Diagnostic or Theragnostic Factor? in Cancers / Cancers (Basel). 2022 Aug 21;14(16):4039. doi: 10.3390/cancers14164039.
2022
AOU Città della Salute di Torino
Rizzo A; Dall'Armellina S; Pizzuto DA; Perotti G; Zagaria L; Lanni V; Treglia G; Racca M; Annunziata S;
Work Placement and Job Satisfaction in Long-Term Childhood Cancer Survivors: The Impact of Late Effects. in Cancers / Cancers (Basel). 2022 Aug 18;14(16):3984. doi: 10.3390/cancers14163984.
2022
AOU Città della Salute di Torino
Dionisi-Vici M; Godono A; Castiglione A; Gatti F; Fortunati N; Clari M; Conti A; Zucchetti G; Biasin E; Varetto A; Pira E; Fagioli F; Brignardello E; Felicetti F;
Evolving Therapeutic Approaches for Older Patients with Acute Myeloid Leukemia in 2021. in Cancers / Cancers (Basel). 2021 Oct 11;13(20):5075. doi: 10.3390/cancers13205075.
2021
AOU Città della Salute di Torino
Urbino I; Secreto C; Olivi M; Apolito V; D'Ardia S; Frairia C; Giai V; Aydin S; Freilone R; Dellacasa C; Giaccone L; Ferrero D; Audisio E; Busca A; Cerrano M;
How Has Prostate Cancer Radiotherapy Changed in Italy between 2004 and 2011? An Analysis of the National Patterns-Of-Practice (POP) Database by the Uro-Oncology Study Group of the Italian Society of Radiotherapy and Clinical Oncology (AIRO). in Cancers / Cancers (Basel). 2021 May 30;13(11):2702. doi: 10.3390/cancers13112702.
2021
AOU Città della Salute di Torino
Mazzeo E; Triggiani L; Frassinelli L; Guarneri A; Bartoncini S; Antognoni P; Gottardo S; Greco D; Borghesi S; Nanni S; Bruni A; Ingrosso G; D'Angelillo RM; Detti B; Francolini G; Magli A; Guerini AE; Arcangeli S; Spiazzi L; Ricardi U; Lohr F; Magrini SM;
New DNA Methylation Signals for Malignant Pleural Mesothelioma Risk Assessment. in Cancers / Cancers (Basel). 2021 May 27;13(11):2636. doi: 10.3390/cancers13112636.
2021
AOU Alessandria
AOU Città della Salute di Torino
Magnani C; Mirabelli D; Libener R; Pirazzini C; La Vecchia M; Sculco M; Ferrante D; Grosso F; Guarrera S; Casalone E; Catalano C; Russo A; Cugliari G; Allione A; Matullo G; Dianzani I;
Systemic Treatment Initiation in Classical and Endemic Kaposi's Sarcoma: Risk Factors and Global Multi-State Modelling in a Monocentric Cohort Study. in Cancers / Cancers (Basel). 2021 May 21;13(11):2519. doi: 10.3390/cancers13112519.
2021
AOU Città della Salute di Torino
Benajiba L; Lambert J; La Selva R; Cochereau D; Baroudjian B; Roux J; Le Goff J; Pages C; Battistella M; Delyon J; Lebbé C;
Biomarkers of Oncogenesis, Adipose Tissue Dysfunction and Systemic Inflammation for the Detection of Hepatocellular Carcinoma in Patients with Nonalcoholic Fatty Liver Disease. in Cancers / Cancers (Basel). 2021 May 11;13(10):2305. doi: 10.3390/cancers13102305.
2021
AOU Città della Salute di Torino
Caviglia GP; Armandi A; Rosso C; Gaia S; Aneli S; Rolle E; Abate ML; Olivero A; Nicolosi A; Guariglia M; Ribaldone DG; Carucci P; Saracco GM; Bugianesi E;
Targeting Chronic Myeloid Leukemia Stem/Progenitor Cells Using Venetoclax-Loaded Immunoliposome. in Cancers / Cancers (Basel). 2021 Mar 15;13(6):1311. doi: 10.3390/cancers13061311.
2021
AOU Alessandria
AO Ordine Mauriziano
AOU Città della Salute di Torino
Saglio G; Circosta P; Aime S; Russo S; Iurlo A; Stagno F; Pregno P; Martino B; Bonifacio M; Binotto G; Bocchia M; Specchia G; Luciano L; Annunziata M; Galimberti S; Pungolino E; Nikougoftar Zarif M; Fava C; Spinelli M; Cignetti A; Gaidano V; Stefania R; Garello F; Houshmand M;
The Landscape of Signaling Pathways and Proteasome Inhibitors Combinations in Multiple Myeloma. in Cancers / Cancers (Basel). 2021 Mar 11;13(6):1235. doi: 10.3390/cancers13061235.
2021
AOU Città della Salute di Torino
Paradzik T; Bandini C; Mereu E; Labrador M; Taiana E; Amodio N; Neri A; Piva R;
Targeting HIF-1? Regulatory Pathways as a Strategy to Hamper Tumor-Microenvironment Interactions in CLL. in Cancers / Cancers (Basel). 2021 Jun 9;13(12):2883. doi: 10.3390/cancers13122883.
2021
AOU Città della Salute di Torino
Vitale C; Griggio V; Riganti C; Todaro M; Kopecka J; Jones R; Salvetti C; Boccellato E; Perutelli F; Voena C; Godio L; Boccadoro M; Coscia M;
Prognostic Impact and Risk Factors of Infections in Patients with Chronic Lymphocytic Leukemia Treated with Ibrutinib. in Cancers / Cancers (Basel). 2021 Jun 29;13(13):3240. doi: 10.3390/cancers13133240.
2021
AOU Città della Salute di Torino
AOU Novara
Foà R; Cuneo A; Gaidano G; Tedeschi A; Coscia M; Molica S; Noto A; Guarente V; Ielo C; Stelitano C; Del Poeta G; Giordano A; Levato L; Rigolin GM; Gentile M; Murru R; De Paoli L; Laurenti L; Vitale C; Chiarenza A; Ciolli S; Frustaci AM; Sportoletti P; Reda G; Visentin A; Giannarelli D; Mauro FR; Martelli M; Girmenia C; et alii...
Front-Line Window Therapy with Temozolomide and Irinotecan in Patients with Primary Disseminated Multifocal Ewing Sarcoma: Results of the ISG/AIEOP EW-2 Study. in Cancers / Cancers (Basel). 2021 Jun 18;13(12):3046. doi: 10.3390/cancers13123046.
2021
AOU Città della Salute di Torino
Asaftei SD; Puma N; Paioli A; Petraz M; Morosi C; Podda M; Tamburini A; Palmerini E; Coccoli L; Grignani G; Manzitti C; Bertulli R; De Leonardis F; Rabusin M; Campello A; Tirtei E; Picci P; Prete A; Longhi A; Fagioli F; Luksch R;
Extending Age Ranges in Breast Cancer Screening in Four European Countries: Model Estimations of Harm-to-Benefit Ratios. in Cancers / Cancers (Basel). 2021 Jul 4;13(13):3360. doi: 10.3390/cancers13133360.
2021
AOU Città della Salute di Torino
Zielonke N; Geuzinge A; Heijnsdijk EAM; Heinävaara S; Senore C; Jarm K; de Koning HJ; van Ravesteyn NT; On Behalf Of The Eu-Topia Consortium;
Impact of Immune Parameters and Immune Dysfunctions on the Prognosis of Patients with Chronic Lymphocytic Leukemia. in Cancers / Cancers (Basel). 2021 Jul 30;13(15):3856. doi: 10.3390/cancers13153856.
2021
AOU Città della Salute di Torino
Vitale C; Boccellato E; Comba L; Jones R; Perutelli F; Griggio V; Coscia M;
Low Levels of Urinary PSA Better Identify Prostate Cancer Patients. in Cancers / Cancers (Basel). 2021 Jul 16;13(14):3570. doi: 10.3390/cancers13143570.
2021
AOU Città della Salute di Torino
Occhipinti S; Mengozzi G; Oderda M; Zitella A; Molinaro L; Novelli F; Giovarelli M; Gontero P;
Analysis of Italian BRCA1/2 Pathogenic Variants Identifies a Private Spectrum in the Population from the Bergamo Province in Northern Italy. in Cancers / Cancers (Basel). 2021 Jan 30;13(3):532. doi: 10.3390/cancers13030532.
2021
AOU Città della Salute di Torino
Figlioli G; De Nicolo A; Catucci I; Manoukian S; Peissel B; Azzollini J; Beltrami B; Bonanni B; Calvello M; Bondavalli D; Pasini B; Vignolo Lutati F; Ogliara P; Zuradelli M; Pensotti V; De Vecchi G; Volorio S; Verderio P; Pizzamiglio S; Matullo G; Aneli S; Birolo G; Zanardi F; Tondini C; Zambelli A; Livraghi L; Franchi M; Radice P; Peterlongo P; et alii...
Allogeneic Stem Cell Transplantation in Mantle Cell Lymphoma in the Era of New Drugs and CAR-T Cell Therapy. in Cancers / Cancers (Basel). 2021 Jan 14;13(2):291. doi: 10.3390/cancers13020291.
2021
AOU Alessandria
AOU Città della Salute di Torino
Re A; Musuraca G; Luminari S; Galimberti S; Ferrero S; Fabbri A; Barbui AM; Chiappella A; Visco C; Marangon M; Zilioli VR; Ladetto M;
Identification of TENM4 as a Novel Cancer Stem Cell-Associated Molecule and Potential Target in Triple Negative Breast Cancer. in Cancers / Cancers (Basel). 2021 Feb 20;13(4):894. doi: 10.3390/cancers13040894.
2021
AOU Città della Salute di Torino
Ruiu R; Barutello G; Arigoni M; Riccardo F; Conti L; Peppino G; Annaratone L; Marchiò C; Mengozzi G; Calogero RA; Cavallo F; Quaglino E;
How Can We Treat Vulvar Carcinoma in Pregnancy? A Systematic Review of the Literature. in Cancers / Cancers (Basel). 2021 Feb 17;13(4):836. doi: 10.3390/cancers13040836.
2021
AOU Città della Salute di Torino
AOU Novara
Asaturova A; Sanguedolce F; Carpenito L; Veggiani C; Dalla Dea G; Ragazzi M; de Biase D; Santandrea G; De Leo A; Zizzo M; Ardighieri L; Bernardelli G; Ricci S; De Giorgi F; Bonacini M; Mastrofilippo V; Aguzzoli L; Sileo FG; D'Ippolito G; Falbo AI; Gugnoni M; Manzotti G; Torricelli F; De Marco L; Zanetti E; Bisagni A; Gelli MC; Zanelli M; Bonasoni MP; et alii...
Lateralized and Segmental Overgrowth in Children. in Cancers / Cancers (Basel). 2021 Dec 7;13(24):6166. doi: 10.3390/cancers13246166.
2021
AOU Città della Salute di Torino
Mussa A; Carli D; Cardaropoli S; Ferrero GB; Resta N;
Efficacy of Front-Line Ibrutinib and Rituximab Combination and the Impact of Treatment Discontinuation in Unfit Patients with Chronic Lymphocytic Leukemia: Results of the Gimema LLC1114 Study. in Cancers / Cancers (Basel). 2021 Dec 31;14(1):207. doi: 10.3390/cancers14010207.
2021
AOU Alessandria
AO Ordine Mauriziano
AOU Città della Salute di Torino
AOU Novara
Piciocchi A; Cuneo A; Foà R; Rigolin GM; Fazi P; Neri A; Guarini A; Raponi S; Nanni M; De Propris MS; Della Starza I; Ibatici A; Murru R; Ruocco V; Del Giudice I; Varettoni M; Molinari A; Gentile M; Chiarenza A; Laurenti L; Gottardi D; Zinzani PL; Gozzetti A; Tani M; Musuraca G; Orsucci L; Re F; Di Renzo N; Liberati AM; et alii...
A Clinical Prognostic Model Based on Machine Learning from the Fondazione Italiana Linfomi (FIL) MCL0208 Phase III Trial. in Cancers / Cancers (Basel). 2021 Dec 31;14(1):188. doi: 10.3390/cancers14010188.
2021
AOU Alessandria
AOU Città della Salute di Torino
Hermine O; Vitolo U; Guarini A; Fabbri A; Patti C; Latte G; Spina M; Pascarella A; Vallisa D; Merli F; Di Renzo N; Cabras MG; Moia R; Volpetti S; Tani M; Del Giudice I; Barbero D; Ghislieri M; Drandi D; Genuardi E; Evangelista A; Passera R; Hoster E; Ferrero S; Zaccaria GM; Kluin-Nelemans HC; Cortelazzo S; Dreyling M; Ladetto M; et alii...
CD200 Baseline Serum Levels Predict Prognosis of Chronic Lymphocytic Leukemia. in Cancers / Cancers (Basel). 2021 Aug 23;13(16):4239. doi: 10.3390/cancers13164239.
2021
AOU Città della Salute di Torino
D'Arena G; Vitale C; Coscia M; Lamorte D; Pietrantuono G; Perutelli F; D'Auria F; Statuto T; Valvano L; Tomasso A; Griggio V; Jones R; Mansueto G; Villani O; D'Agostino S; Viglioglia V; De Feo V; Calapai F; Mannucci C; Sgambato A; Efremov DG; Laurenti L;
Genomic Instability in Multiple Myeloma: A "Non-Coding RNA" Perspective. in Cancers / Cancers (Basel). 2021 Apr 28;13(9):2127. doi: 10.3390/cancers13092127.
2021
AOU Città della Salute di Torino
Taiana E; Gallo Cantafio ME; Favasuli VK; Bandini C; Viglietto G; Piva R; Neri A; Amodio N;
Multiple Myeloma Patients Undergoing Carfilzomib: Development and Validation of a Risk Score for Cardiovascular Adverse Events Prediction. in Cancers / Cancers (Basel). 2021 Apr 1;13(7):1631. doi: 10.3390/cancers13071631.
2021
AOU Città della Salute di Torino
Astarita A; Mingrone G; Airale L; Vallelonga F; Covella M; Catarinella C; Cesareo M; Bruno G; Leone D; Giordana C; Cetani G; Salvini M; Gay F; Bringhen S; Rabbia F; Veglio F; Milan A;
Prognostic Role of Serum Cytokeratin-19 Fragment (CYFRA 21-1) in Patients with Hepatocellular Carcinoma. in Cancers / Cancers (Basel). 2020 Sep 28;12(10):2776. doi: 10.3390/cancers12102776.
2020
AOU Città della Salute di Torino
Caviglia GP; Ciruolo M; Olivero A; Carucci P; Rolle E; Rosso C; Abate ML; Risso A; Ribaldone DG; Tandoi F; Saracco GM; Bugianesi E; Gaia S;
Alpha-Fetoprotein, Protein Induced by Vitamin K Absence or Antagonist II and Glypican-3 for the Detection and Prediction of Hepatocellular Carcinoma in Patients with Cirrhosis of Viral Etiology. in Cancers / Cancers (Basel). 2020 Oct 31;12(11):3218. doi: 10.3390/cancers12113218.
2020
AOU Città della Salute di Torino
Caviglia GP; Ciruolo M; Abate ML; Carucci P; Rolle E; Rosso C; Olivero A; Troshina G; Risso A; Nicolosi A; Ribaldone DG; Armandi A; Tandoi F; Saracco GM; Bugianesi E; Ciancio A; Gaia S;
Multimodal Treatment of Advanced Mucosal Melanoma in the Era of Modern Immunotherapy. in Cancers / Cancers (Basel). 2020 Oct 26;12(11):3131. doi: 10.3390/cancers12113131.
2020
AOU Città della Salute di Torino
Teterycz P; Czarnecka AM; Indini A; Spa?ek MJ; Labianca A; Rogala P; Cybulska-Stopa B; Quaglino P; Ricardi U; Badellino S; Szumera-Cie?kiewicz A; Falkowski S; Mandala M; Rutkowski P;
Diagnostic and Therapeutic Challenges in the Management of Intermediate and Frail Elderly Multiple Myeloma Patients. in Cancers / Cancers (Basel). 2020 Oct 24;12(11):3106. doi: 10.3390/cancers12113106.
2020
AOU Città della Salute di Torino
Bonello F; Boccadoro M; Larocca A;
Bone Marrow-Sparing IMRT in Anal Cancer Patients Undergoing Concurrent Chemo-Radiation: Results of the First Phase of a Prospective Phase II Trial. in Cancers / Cancers (Basel). 2020 Nov 9;12(11):3306. doi: 10.3390/cancers12113306.
2020
AOU Città della Salute di Torino
Arcadipane F; Silvetti P; Olivero F; Gastino A; De Luca V; Mistrangelo M; Cassoni P; Racca P; Gallio E; Lesca A; Fiandra C; Ricardi U; Franco P;
DNA Methylation of FKBP5 as Predictor of Overall Survival in Malignant Pleural Mesothelioma. in Cancers / Cancers (Basel). 2020 Nov 21;12(11):3470. doi: 10.3390/cancers12113470.
2020
AOU Città della Salute di Torino
Cugliari G; Catalano C; Guarrera S; Allione A; Casalone E; Russo A; Grosso F; Ferrante D; Viberti C; Aspesi A; Sculco M; Pirazzini C; Libener R; Mirabelli D; Magnani C; Dianzani I; Matullo G;
(18)F-FDG Pet Parameters and Radiomics Features Analysis in Advanced Nsclc Treated with Immunotherapy as Predictors of Therapy Response and Survival. in Cancers / Cancers (Basel). 2020 May 5;12(5):1163. doi: 10.3390/cancers12051163.
2020
AOU San Luigi di Orbassano
AOU Città della Salute di Torino
Veltri A; Novello S; Arena V; Racca M; Scapoli P; Liberini V; Passera R; Gallio E; Rampado O; Reale ML; Bertaglia V; Ceci F; Polverari G; Deandreis D;
Immune-Complexome Analysis Identifies Immunoglobulin-Bound Biomarkers That Predict the Response to Chemotherapy of Pancreatic Cancer Patients. in Cancers / Cancers (Basel). 2020 Mar 21;12(3):746. doi: 10.3390/cancers12030746.
2020
AOU San Luigi di Orbassano
AOU Città della Salute di Torino
Hanash SM; Evangelista A; Satolli MA; Spadi R; Giordano D; Momin AA; Capello M; Hong W; Katayama H; Ferrero G; Follia L; Mandili G; Cordero F; Novelli F;
Small Non-Coding RNA Profiling in Plasma Extracellular Vesicles of Bladder Cancer Patients by Next-Generation Sequencing: Expression Levels of miR-126-3p and piR-5936 Increase with Higher Histologic Grades. in Cancers / Cancers (Basel). 2020 Jun 9;12(6):1507. doi: 10.3390/cancers12061507.
2020
AOU Città della Salute di Torino
Sabo AA; Birolo G; Naccarati A; Dragomir MP; Aneli S; Allione A; Oderda M; Allasia M; Gontero P; Sacerdote C; Vineis P; Matullo G; Pardini B;
Prognostic Significance of PET/CT in Patients with Chronic Lymphocytic Leukemia (CLL) Treated with Frontline Chemoimmunotherapy. in Cancers / Cancers (Basel). 2020 Jul 3;12(7):1773. doi: 10.3390/cancers12071773.
2020
AOU Città della Salute di Torino
Porrazzo M; Nicolai E; Riminucci M; Vitale C; Coscia M; De Paoli L; Rago A; Buscicchio G; Maestrini G; Ligia S; Di Prima A; Corsi A; Caronna R; Gaidano G; Mauro FR;
Autoimmune Complications in Chronic Lymphocytic Leukemia in the Era of Targeted Drugs. in Cancers / Cancers (Basel). 2020 Jan 23;12(2):282. doi: 10.3390/cancers12020282.
2020
AOU Città della Salute di Torino
Vitale C; Montalbano MC; Salvetti C; Boccellato E; Griggio V; Boccadoro M; Coscia M;
High Throughput Molecular Characterization of Normal Karyotype Acute Myeloid Leukemia in the Context of the Prospective Trial 02/06 of the Northern Italy Leukemia Group (NILG). in Cancers / Cancers (Basel). 2020 Aug 11;12(8):2242. doi: 10.3390/cancers12082242.
2020
AOU Alessandria
AOU Città della Salute di Torino
Campiotti L; Corradini P; Todisco E; Ciceri F; Tajana M; Mattei D; Scattolin A; Borlenghi E; Cavattoni I; De Paoli L; Terruzzi E; Audisio E; Gianfaldoni G; Stefanoni P; Caprioli C; Oldani E; Lussana F; Intermesoli T; Elidi L; Buklijas K; Michelato A; Pavoni C; Zanghì P; Cavagna R; Salmoiraghi S; Fracchiolla N; Bassan R; Rambaldi A; Spinelli O; et alii...
Liquid Biopsy Testing Can Improve Selection of Advanced Non-Small-Cell Lung Cancer Patients to Rechallenge with Gefitinib. in Cancers / Cancers (Basel). 2019 Sep 25;11(10):1431. doi: 10.3390/cancers11101431.
2019
ASL Alessandria
AOU Città della Salute di Torino
Normanno N; Cappuzzo F; Ciuffreda L; de Marinis F; Frassoldati A; Fasola G; Romano G; Tiseo M; Giannetta L; Battiloro C; Buosi R; Foltran L; Chiari R; Bidoli P; Finocchiaro G; Morabito A; Piccirillo MC; Sacco A; Esposito Abate R; Pasquale R;
Lenalidomide Maintenance with or without Prednisone in Newly Diagnosed Myeloma Patients: A Pooled Analysis. in Cancers / Cancers (Basel). 2019 Nov 5;11(11):1735. doi: 10.3390/cancers11111735.
2019
AOU Città della Salute di Torino
Bonello F; Pulini S; Ballanti S; Gentile M; Spada S; Annibali O; Omedé P; Ronconi S; Cangialosi C; Podda L; Palmas A; Malfitano A; Rivoli G; Belotti A; Ciambelli F; Vincelli ID; Cafro AM; Innao V; Palumbo A; Sonneveld P; Spencer A; Hájek R; Boccadoro M; Gay F;
Cardiovascular Organ Damage and Blood Pressure Levels Predict Adverse Events in Multiple Myeloma Patients Undergoing Carfilzomib Therapy. in Cancers / Cancers (Basel). 2019 May 3;11(5):622. doi: 10.3390/cancers11050622.
2019
AOU Città della Salute di Torino
Bruno G; Bringhen S; Maffei I; Iannaccone A; Crea T; Ravera A; Astarita A; Vallelonga F; Salvini M; Gay F; Veglio F; Milan A;
TERT Promoter Mutations are Associated with Visceral Spreading in Melanoma of the Trunk. in Cancers / Cancers (Basel). 2019 Mar 30;11(4):452. doi: 10.3390/cancers11040452.
2019
AOU Città della Salute di Torino
Osella-Abate S; Bertero L; Senetta R; Mariani S; Lisa F; Coppola V; Metovic J; Pasini B; Puig S S; Fierro MT; Manrique-Silva E; Kumar R; Nagore E; Cassoni P; Ribero S;
Improvement of Metastatic Colorectal Cancer Patient Survival: Single Institution Experience. in Cancers / Cancers (Basel). 2019 Mar 15;11(3):369. doi: 10.3390/cancers11030369.
2019
AOU Città della Salute di Torino
Fenocchio E; Colombi F; Calella MG; Filippi R; Depetris I; Chilà G; Lombardi P; Marino D; Cagnazzo C; Ferraris R; Vaira M; Aglietta M; Leone F;
Elevated Lactate Dehydrogenase Has Prognostic Relevance in Treatment-Naïve Patients Affected by Chronic Lymphocytic Leukemia with Trisomy 12. in Cancers / Cancers (Basel). 2019 Jun 26;11(7):896. doi: 10.3390/cancers11070896.
2019
AOU Città della Salute di Torino
Autore F; Strati P; Innocenti I; Corrente F; Trentin L; Cortelezzi A; Visco C; Coscia M; Cuneo A; Gozzetti A; Mauro FR; Frustaci AM; Gentile M; Morabito F; Molica S; Falcucci P; D'Arena G; Murru R; Vincelli D; Efremov DG; Ferretti A; Rigolin GM; Vitale C; Tisi MC; Reda G; Visentin A; Sica S; Foà R; Ferrajoli A; et alii...
Longitudinal Monitoring of Alpha-Fetoprotein by Dried Blood Spot for Hepatoblastoma Screening in Beckwith?Wiedemann Syndrome. in Cancers / Cancers (Basel). 2019 Jan 14;11(1):86. doi: 10.3390/cancers11010086.
2019
AOU Città della Salute di Torino
Mussa A; Ciuffreda VP; Sauro P; Pagliardini V; Pagliardini S; Carli D; Kalish JM; Fagioli F; Pavanello E; Ferrero GB;
Therapeutic Monoclonal Antibodies and Antibody Products: Current Practices and Development in Multiple Myeloma. in Cancers / Cancers (Basel). 2019 Dec 19;12(1):15. doi: 10.3390/cancers12010015.
2019
AOU Città della Salute di Torino
Bonello F; Mina R; Boccadoro M; Gay F;
Pursuing a Curative Approach in Multiple Myeloma: A Review of New Therapeutic Strategies. in Cancers / Cancers (Basel). 2019 Dec 13;11(12):2015. doi: 10.3390/cancers11122015.
2019
AOU Città della Salute di Torino
D'Agostino M; Bertamini L; Oliva S; Boccadoro M; Gay F;
Factors Influencing the Clinical Presentation of Breakthrough Pain in Cancer Patients. in Cancers / Cancers (Basel). 2018 Jun 1;10(6):175. doi: 10.3390/cancers10060175.
2018
AO Cuneo
ASL Alessandria
AOU Città della Salute di Torino
Aielli F; Valle A; Tonini G; Sofia M; Papa A; Scelzi E; Ricci S; Orsetti R; De Santis S; Pascoletti G; Moroso S; Menardo V; Miotti D; Melotti RM; Mattioli R; Mazzei T; Masedu F; Mameli S; Palermo L; Liguori S; Guardamagna V; Iaffaioli V; Fusco F; Cartenì G; Chiurazzi B; Costanzo BVP; Degiovanni D; Blasi L; Bandera M; et alii...
Cancer Stem Cells, Bone and Tumor Microenvironment: Key Players in Bone Metastases. in Cancers / Cancers (Basel). 2018 Feb 20;10(2):56. doi: 10.3390/cancers10020056.
2018
AOU Città della Salute di Torino
Roato I; Ferracini R;
Next Generation Immunotherapy for Pancreatic Cancer: DNA Vaccination is Seeking New Combo Partners. in Cancers / Cancers (Basel). 2018 Feb 16;10(2):51. doi: 10.3390/cancers10020051.
2018
AOU Città della Salute di Torino
Cappello P; Curcio C; Mandili G; Roux C; Bulfamante S; Novelli F;